Ambitious federal study did not curb opioid overdose deaths
In 2019, amid an ever-worsening drug disaster, the federal authorities launched a analysis examine with an formidable objective: to decrease opioid overdoses in collaborating communities by 40% utilizing evidence-based interventions like distributing naloxone and offering entry to dependancy medicines.
However communities that applied the general public well being methods didn’t see a statistically important discount in opioid overdose deaths, in line with information revealed Sunday within the New England Journal of Medication.
Given the examine’s easy premise — that serving to communities use confirmed methods might assist forestall deaths — the outcomes got here as a shock. However its leaders warn in opposition to making an excessive amount of of the disappointing information, citing the fast-changing drug provide and, critically, the backdrop of the Covid-19 pandemic.
“We began this examine in January of 2020, and guess what occurred in March of 2020?” Redonna Chandler, the Nationwide Institute on Drug Abuse official who directed the analysis undertaking. “And whereas our communities continued working within the background, we weren’t capable of get into hospitals. We weren’t capable of get into jails. We weren’t capable of get into lots of the locations and areas the place we needed to implement our evidence-based practices.”
Actually, of the tons of of particular person interventions that communities had deliberate to make use of as a part of the examine, simply 38% had been applied by the beginning of the yr that information was analyzed, in line with the NEJM evaluation.
The Nationwide Institutes of Well being launched the initiative, often called the HEALing Communities Examine — brief for Serving to Finish Habit Lengthy-term — in April 2018. It awarded $344 million to collaborating communities, utilizing funds that Congress had appropriated for substance use analysis the earlier yr.
“Now could be the time to channel the efforts of the scientific group to ship efficient — and sustainable — options to this formidable public well being problem,” a number of prime NIH officers, together with then-director Francis Collins and NIDA director Nora Volkow, wrote in 2018 when the undertaking kicked off.
The examine targeted on 67 communities throughout Massachusetts, New York, Kentucky, and Ohio. Roughly half have been picked to implement their overdose-prevention methods starting in 2020; the remaining put their methods into place starting in 2022, following the comparability interval between the 2 teams.
Interventions included rising entry to medicines like methadone and buprenorphine by decreasing restrictions, supporting well being care suppliers, and dealing with jails and prisons. It additionally included training surrounding opioid prescribing, and bolstering the distribution of naloxone, a drugs used to reverse opioid overdoses.
Through the comparability interval, the communities that put their methods into place sooner skilled 47.2 opioid-related overdose deaths per 100,000 folks; the communities that hadn’t begun skilled 51.7. Regardless of a virtually 10% decrease demise price in communities that had applied their methods, nonetheless, the outcomes fell in need of statistical significance.
In statements, federal well being officers solid the examine as no less than a partial victory. Whereas the interventions didn’t meaningfully cut back overdose deaths, the officers argued, they set the stage for future motion and created a framework to assist hard-hit communities select new coverage approaches and start to implement them, with the hope that with extra time and with out Covid-19, deaths would fall.
Nora Volkow, the NIDA director, mentioned that rising use of stimulants like methamphetamine and cocaine, and the proliferation of fentanyl, imply society should “proceed creating new instruments and approaches” for stopping overdose deaths. Miriam Delphin-Rittmon, the director of the Substance Abuse and Psychological Well being Companies Administration, mentioned the examine “acknowledges there isn’t any fast repair.”
And in an interview, Chandler, the director of the examine, burdened that the outcomes shouldn’t problem what analysis has lengthy demonstrated: There’s a “mountain of proof,” she mentioned, supporting the idea that instruments like naloxone, medicines for opioid use dysfunction, and safer prescribing methods, save lives. The problem, Chandler mentioned, lies in implementation — not the methods themselves.
The examine launched Sunday, she mentioned, “doesn’t negate, in any approach, the proof that implies the strengths of these interventions.”
STAT’s protection of continual well being points is supported by a grant from Bloomberg Philanthropies. Our monetary supporters will not be concerned in any choices about our journalism.
